ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,875.35
-0.31%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Protara Therapeutics Inc (TARA)

  7. Protara Therapeutics Inc (TARA) 뉴스

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TARA
일자시간출처헤드라인심볼기업
2024/05/1808:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/05/1107:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/05/1013:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TARAProtara Therapeutics Inc
2024/05/1005:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TARAProtara Therapeutics Inc
2024/05/0221:00GlobeNewswire Inc.Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:TARAProtara Therapeutics Inc
2024/04/0521:04GlobeNewswire Inc.Protara Therapeutics Announces Oversubscribed $45 Million Private Placement FinancingNASDAQ:TARAProtara Therapeutics Inc
2024/04/0521:02GlobeNewswire Inc.Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral NutritionNASDAQ:TARAProtara Therapeutics Inc
2024/04/0521:00GlobeNewswire Inc.Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBCNASDAQ:TARAProtara Therapeutics Inc
2024/03/1321:00GlobeNewswire Inc.Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:TARAProtara Therapeutics Inc
2024/02/2822:00GlobeNewswire Inc.Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/2406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/1306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/0606:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/0606:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2024/01/0606:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
2023/11/3022:30GlobeNewswire Inc.Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic OncologyNASDAQ:TARAProtara Therapeutics Inc
2023/11/1514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TARAProtara Therapeutics Inc
2023/11/0321:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TARAProtara Therapeutics Inc
2023/11/0321:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TARAProtara Therapeutics Inc
2023/11/0321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TARAProtara Therapeutics Inc
2023/11/0321:00GlobeNewswire Inc.Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business UpdateNASDAQ:TARAProtara Therapeutics Inc
2023/10/2321:00GlobeNewswire Inc.Protara Therapeutics Announces Dosing of First Patient in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic MalformationsNASDAQ:TARAProtara Therapeutics Inc
2023/09/2021:30GlobeNewswire Inc.Protara Therapeutics Announces Dosing of First Patient in Phase 1b/2 ADVANCED-2 Trial of TARA-002 in NMIBC Patients with High Grade Carcinoma in SituNASDAQ:TARAProtara Therapeutics Inc
2023/09/0520:30GlobeNewswire Inc.Protara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:TARAProtara Therapeutics Inc
 검색 관련기사 보기:NASDAQ:TARA

최근 히스토리

ASX
LMLN
ASX
TGNR
EU
Y949S
Y949S
AMEX
GURU
Global X Guru Index ETF
BIT
F16634
Vontobel Financial Produ...
COIN
HIDEOUSUST
Hideous
BIT
F13777
Vontobel Financial Produ...
BOV
MGLUH140
MGLUH140 Ex:1,39
TSXV
RGD
Reunion Gold
ASX
SGR
Star Entertainment
BIT
UI048D
Unicredit Bank
BIT
CRL
Carel Industries
TG
51KB
AVITA Medical
COIN
PAIEUR
Project Pai
NYSE
MCN
Madison Covered Call and...
BIT
S29107
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유